LCTX
AMEX · Biotechnology
Lineage Cell Therapeutics In
$1.14
+0.02 (+1.79%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,445.6% upside
Low Target
$29.91
Average Target
$40.42
High Target
$53.83
Current Price
$1.14
Current
$1.14
$1.14
Target
$40.42
$40.42
$29.91
$40.42 avg
$53.83
Scenario Analysis
Bear Case
$29.91
2,523.7%
Low target
Base Case
$40.42
+3,445.6%
Avg target
Bull Case
$53.83
+4,621.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.09
-45.5% from high
52-Week Low
$0.95
+20.0% from low
Target vs 52W High
$40.42
+1,834.0% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-0.03
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |